DIA
GBIO

Dana Investment Advisors’s Generation Bio GBIO Stock Holding History

Dana Investment Advisors’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,610
Closed -$433K – 323
2021
Q2 		$433K Buy
1,610
+229
+17% +$68.5K 0.02% 265
2021
Q1 		$393K Buy
+1,381
New +$442K 0.02% 271

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return

Dana Investment Advisors's GBIO Position: Q3 2021 in Review

Dana Investment Advisors sold out of Generation Bio (GBIO) in Q3 2021, closing a stake of 1,610 shares — an estimated $433K sold.

Dana Investment Advisors first reported a position in GBIO in Q1 2021 and held it in 2 quarters. The position peaked at $433K in Q2 2021. 81 funds tracked by Wall St. Rank hold GBIO as of Q3 2021.

  • Dana Investment Advisors reported no remaining Generation Bio position as of Q3 2021 after selling out during the quarter.
  • Dana Investment Advisors sold 1,610 Generation Bio shares in Q3 2021, an estimated $433K.
  • Dana Investment Advisors first reported a position in Generation Bio in Q1 2021 and held it in 2 quarters.
  • Dana Investment Advisors's Generation Bio position peaked at $433K in Q2 2021.
  • 81 funds tracked by Wall St. Rank held Generation Bio as of Q3 2021.

Based on Dana Investment Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.